You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

Article metrics

Article menu

Download PDFPDF

XML
Basic tumor immunology
Original research
Bivalent therapeutic vaccine against HPV16/18 genotypes consisting of a fusion protein between the extra domain A from human fibronectin and HPV16/18 E7 viral antigens

 

Online download statistics by month:

Online download statistics by month: June 2020 to March 2024

AbstractFullPdf
Jun 202015815852
Jul 202015315353
Aug 2020353613
Sep 2020636316
Oct 2020626236
Nov 2020343414
Dec 2020333316
Jan 2021484822
Feb 2021535320
Mar 2021636328
Apr 2021494929
May 2021343425
Jun 2021444430
Jul 2021424224
Aug 2021343428
Sep 2021393918
Oct 2021414122
Nov 2021413929
Dec 2021393918
Jan 2022495216
Feb 2022242413
Mar 2022444622
Apr 2022536133
May 2022434729
Jun 2022474822
Jul 2022273017
Aug 2022434312
Sep 2022373718
Oct 2022455228
Nov 2022485026
Dec 2022292917
Jan 2023262616
Feb 2023414114
Mar 2023464716
Apr 2023192117
May 2023151514
Jun 2023151511
Jul 2023101012
Aug 202313136
Sep 202312125
Oct 2023191912
Nov 2023252514
Dec 2023424416
Jan 2024202119
Feb 2024191913
Mar 2024262643
Total19021937974